We also demonstrate that the loading process of DOX and the freezing for long-term storage and ease of treatment does not affect (a) PLT function, in particular the membrane integrity or reactivity to tumour cell-derived TF and thrombin, (b) the capacity to generate PEV, and (c) the targeting and transfer of DOX to cancer cells. The gene discussed is TF; the disease is neoplasm.